15(th) Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USA: Symposia - Oral Communications - Late Breaking Abstracts (Clinical Trial Alzheimer’s Disease)

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734311/
https://www.ncbi.nlm.nih.gov/pubmed/36471007
http://dx.doi.org/10.14283/jpad.2022.96
_version_ 1784846562196717568
collection PubMed
description
format Online
Article
Text
id pubmed-9734311
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-97343112022-12-12 15(th) Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USA: Symposia - Oral Communications - Late Breaking Abstracts (Clinical Trial Alzheimer’s Disease) J Prev Alzheimers Dis Article Springer International Publishing 2022-12-03 2022 /pmc/articles/PMC9734311/ /pubmed/36471007 http://dx.doi.org/10.14283/jpad.2022.96 Text en © Serdi 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
15(th) Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USA: Symposia - Oral Communications - Late Breaking Abstracts (Clinical Trial Alzheimer’s Disease)
title 15(th) Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USA: Symposia - Oral Communications - Late Breaking Abstracts (Clinical Trial Alzheimer’s Disease)
title_full 15(th) Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USA: Symposia - Oral Communications - Late Breaking Abstracts (Clinical Trial Alzheimer’s Disease)
title_fullStr 15(th) Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USA: Symposia - Oral Communications - Late Breaking Abstracts (Clinical Trial Alzheimer’s Disease)
title_full_unstemmed 15(th) Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USA: Symposia - Oral Communications - Late Breaking Abstracts (Clinical Trial Alzheimer’s Disease)
title_short 15(th) Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USA: Symposia - Oral Communications - Late Breaking Abstracts (Clinical Trial Alzheimer’s Disease)
title_sort 15(th) conference clinical trials alzheimer’s disease, november 29- december 2, 2022, san francisco, ca, usa: symposia - oral communications - late breaking abstracts (clinical trial alzheimer’s disease)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734311/
https://www.ncbi.nlm.nih.gov/pubmed/36471007
http://dx.doi.org/10.14283/jpad.2022.96

Ejemplares similares